Muscleblind-like (MBNL) proteins, regulators of developmentally programmed alternative splicing, harbor tandem CCCH zinc-finger (ZnF) domains that target pre-mRNAs containing YGCU(U/G)Y sequence elements (where Y is a pyrimidine). In myotonic dystrophy, reduced levels of MBNL proteins lead to aberrant alternative splicing of a subset of pre-mRNAs. The crystal structure of MBNL1 ZnF3/4 bound to r(CGCUGU) establishes that both ZnF3 and ZnF4 target GC steps, with site-specific recognition mediated by a network of hydrogen bonds formed primarily with main chain groups of the protein. The relative alignment of ZnF3 and ZnF4 domains is dictated by the topology of the interdomain linker, with a resulting antiparallel orientation of bound GC elements, supportive of a chain-reversal loop trajectory for MBNL1-bound pre-mRNA targets. We anticipate that MBNL1-mediated targeting of looped RNA segments proximal to splice-site junctions could contribute to pre-mRNA alternative-splicing regulation.
The generation of functionally diverse proteins required for cell growth and differentiation in metazoan organisms is critically dependent on alternative splicing of pre-mRNAs. Alternative-splicing regulators control the expression of tissue-specific or developmental stage-specific protein isoforms through binding either to splice sites directly or to other sequences in the pre-mRNA, thereby enhancing or repressing the inclusion of alternative exons 1 .
The proteins of the MBNL family have been identified as important tissue-specific alternative-splicing regulators that have a key role in terminal muscle differentiation 2 . MBNL proteins promote splice-site choice appropriate for adult muscle tissues, and they act as either activators or repressors of splicing on different transcripts 3 . Postnatal activation of MBNL proteins leads to repression of fetal splicing patterns in numerous terminal muscle-differentiation transcripts and to the expression of adult protein isoforms 4 . This normal splicing pattern is altered specifically in the neuromuscular disease myotonic dystrophy (DM), in part owing to inactivation of MBNL. Several genes, including the insulin receptor (INSR) and skeletal muscle iontransporter chloride channel 1 (CLCN1), follow aberrant alternative mRNA splicing in myotonic dystrophy tissues, ultimately causing the clinical symptoms 5, 6 .
The genetic basis of myotonic dystrophy is an expansion of CTG trinucleotide repeats in the 3¢ untranslated region of the dystrophia myotonica protein kinase (DMPK) gene (DM1) 7 , or a large CCTG repeat expansion in intron 1 of the zinc finger 9 (ZNF9) gene (DM2) 8 . MBNL proteins have been shown to accumulate with both CUGand CCUG-expanded repeat-bearing transcripts in nuclear foci and to bind CHG and CHHG repeats (where H is A, U or C) in a length-dependent manner 9, 10 .
According to the MBNL-based loss-of-function hypothesis for myotonic dystrophy pathogenesis supported by mouse models, sequestration of MBNL proteins associated with RNAs containing large CUG-and CCUG-repeat expansions in ribonuclear foci leads to misregulated alternative splicing 9, [11] [12] [13] . Although MBNL proteins are key targets in RNA-mediated pathogenesis, the additional factors CUG triplet repeat, RNA binding protein 1 (CUGBP1) and Heterogeneous nuclear ribonucleoprotein H (hnRNP H) have also been shown to contribute independently to aberrant splicing in myotonic dystrophy cells [14] [15] [16] .
There are three MBNL genes in humans: MBNL1, MBNL2 and MBNL3. Of these, MBNL1, which is expressed at high levels in muscle, seems to promote muscle differentiation and has a pivotal role in the pathogenesis of muscle disease in myotonic dystrophy. MBNL3, which is expressed predominantly in the placenta and not in muscles, seems to function in an opposing manner by inhibiting the expression of muscle-differentiation markers 11, 17 . MBNL2, found at similar levels in all tissues, has a major role in cytoplasmic mRNA localization 18 .
Each of the three human MBNL proteins contain four highly conserved ZnF RNA binding domains of the CCCH type, arranged in tandem pairs that are positioned toward the N-terminal segment (ZnF1 and ZnF2) and in the middle (ZnF3 and ZnF4) of the polypeptide chain (Fig. 1a,b ). ZnF1 and ZnF3 show CX 7 CX 6 CX 3 H spacing between the zinc-coordinated residues, whereas ZnF2 and ZnF4 share the CX 7 CX 4 CX 3 H sequence (Fig. 1c) . Within each tandem segment, vertebrate proteins are 99% identical; the most distantly related muscleblind proteins, which contain only one ZnF pair, share 67% identity with human MBNL1 (Fig. 1c) . Three linkers of 14 amino acids, 110 amino acids and 16 amino acids separate the ZnF domains in MBNL1 (Fig. 1a) .
Tandem CCCH ZnF domains were first structurally characterized in the TIS11d protein, a member of the tristetrapolin (TTP) protein family, which is involved in the control of the inflammatory response and required for the rapid degradation of mRNAs that contain an AU-rich element (ARE) in their 3¢ untranslated region. The NMR structure of TIS11d bound to a model AU-rich RNA element shows that each of two ZnFs recognizes a UAUU repeat through stacking interactions and hydrogen bonds to the Watson-Crick edges of the bases 19 . Unexpectedly, the sequence specificity is achieved primarily through interactions mediated by the protein backbone.
Full-length MBNL proteins containing four ZnF domains have been shown to regulate alternative-splicing events within the cardiac troponin T (cTNT) pre-mRNA, where the RNA target contains two YGCU(G/U)Y intronic sequence motifs near the alternative exon 3 . To elucidate the principles of YGCU(G/U)Y element recognition by the CCCH ZnF motifs of MBNL proteins, we solved the crystal structures of two tandem ZnF domains (ZnF1/2 and ZnF3/4) of human MBNL1 in the free form, as well as the crystal structure of second tandem ZnF3/4 domain bound to an r(CGCUGU) oligonucleotide.
Both tandem ZnF domains adopt a previously uncharacterized symmetric overall fold, in which the two ZnFs are connected by a structured linker that orients their RNA binding surfaces away from each other. This arrangement results in an antiparallel orientation of the two single-stranded RNA chains bound by ZnF3 and ZnF4 in the complex. The structure of the complex highlights how ZnF3 binds GC and ZnF4 binds GCU sequences, thereby revealing a common GC sequence-recognition motif. Our structural results and binding studies indicate that the tandem ZnF domains of MBNL1 target two separated GC(U) sites within a longer mRNA, thereby inducing a chain-reversal trajectory in the bound RNA.
RESULTS
Choice of protein and RNA constructs Both ZnF1/2 and ZnF3/4 constructs (Fig. 1b) showed well-dispersed 15 N-HSQC NMR spectra, with ZnF3/4 having the higher-quality spectrum. Each of eight RNA sequence variants with the consensus YGCU(G/U)Y 6-nucleotide (nt) sequence caused similar chemical shift changes in several ZnF3/4 residues (data not shown), consistent with protein-RNA complex formation.
Crystallization and structure determination
We successfully grew diffraction-quality crystals of individual ZnF1/2 (2.7-Å resolution, space group P3 1 ) and ZnF3/4 (1.5 Å , P2 1 ) constructs in the free form, and also of ZnF3/4 bound to an r(CGCUGU) sequence (1.7Å , P2 1 ). We determined the structures of free ZnF1/2 and ZnF3/4 by SAD phasing on zinc atoms (Methods) and solved the structure of the complex by molecular replacement, using the refined X-ray structure of the free ZnF3/4 as a search model. The structure contains four protein molecules, each containing ZnF3 and ZnF4 motifs, and 16 RNA nucleotides originating from four 6-nt RNA strands in the asymmetric unit. A difference electron-density omit map for the bound RNA segment of the complex is shown in Supplementary Figure 1 online.
Structure of MBNL1 tandem ZnF1/2 and ZnF3/4 domains The ZnF3/4 domain in both the free (Fig. 1d) and r(CGCUGU)-bound states, as well as ZnF1/2 in the free state, adopt folds in which structurally similar ZnFs are related by a two-fold rotation axis. Three cysteine residues and one histidine residue coordinate the zinc atom in each finger (Fig. 1c,d) . In all ZnFs, there is a short a-helix between the first and the second coordinated cysteines. A 3 10 -helix element is and Gallus gallus (Gg; GenBank CAG31624.1) MBNL1, Drosophila melanogaster ZnF1/2 (Dm; GenBank AAC01949.1) and Caenorhabditis elegans Mbl (Ce; GenBank NP_510746.1). Cysteine and histidine residues coordinated to zinc are highlighted in blue. Secondary-structure alignment of human MBNL1 ZnF1/2 and ZnF3/4 is shown above the sequences. Numbering above and below the sequences corresponds to human MBNL1 ZnF1/2 and ZnF3/4, respectively. Asterisks denote residues that form hydrogen bonds with RNA bases via their backbone functional groups; triangles indicate aromatic and arginine residues involved in base stacking with RNA bases; dots mark acidic residues interacting with RNA. found between the second and the third coordinated cysteines in ZnF1 and ZnF3, which have spacing of 2 residues longer than that found in ZnF2 and ZnF4. Otherwise, the overall fold of all four MBNL1 ZnFs is virtually the same.
A three-stranded b-sheet positioned between the tandem ZnF domains determines their antiparallel orientation relative to each other for both ZnF1/2 and ZnF3/4 (Fig. 1d) . ZnF1/2 contains an extended a-helix at the C terminus ( Supplementary Fig. 2a online) comprising residues Pro73 to Gly83 and has an interdomain linker 2 residues shorter than that found in ZnF3/4 (Fig. 1c) . Other than these differences, the peptide backbone topology of ZnF1/2 is essentially the same as that of ZnF3/4 (pairwise Ca r.m.s. deviation of 1.17 Å for 62 matching residues; Fig. 1c,d) .
The 16-residue (Pro205 tp Val220) linker connecting the ZnF3 and ZnF4 domains participates in the formation of a central b-sheet (Fig. 1d) stabilized by six NH-O main chain hydrogen bonds involving the ZnF3 N-terminal segment (Asp180 to Val184) and the interdomain linker sequence (Asp212 to Val220) (Fig. 1e) . The solvent-exposed face of the b-sheet projects a hydrophilic surface, whereas its buried face is lined with conserved hydrophobic residues.
Crystal packing and stoichiometry of the complex Different packing interactions are observed in the crystal lattices of free ZnF1/2 ( Supplementary Fig. 2a ) and ZnF3/4 ( Supplementary  Fig. 2b,c) . The integrated structural unit of the complex shown in Figure 2 contains two ZnF3/4 domains bound to four RNA strands and includes protein molecules A and B and RNA molecules E and F within the asymmetric unit; it also contains two symmetry-related RNA molecules that interact with protein molecule A, namely E s and the C1 nucleotide of molecule F s . Three out of four ZnF domains in this complex (ZnF3 and ZnF4 of molecule A and ZnF3 of molecule B) bind RNA, with the remaining ZnF (ZnF4 of molecule B) involved in protein-protein contacts (Fig. 2b) . The two ZnF3/4 molecules in the crystals of both the free ( It is conceivable that the dimerization of ZnF3/4 observed in crystals of both the free (Fig. 2a) and RNA-bound ( Fig. 2b) states of MBNL1 could originate from crystal lattice contacts, and it remains to be demonstrated whether such dimerization also occurs in solution.
RNA binding surfaces as protein-protein interacting domains
The same surface of ZnF4 with highly conserved interfacial residues is involved in protein-RNA (Fig. 2d , ZnF4 molecule A) and proteinprotein (Fig. 2c , ZnF4 molecule B) interactions in the crystal structure of the MBNL1 ZnF3/4-r(CGCUGU) complex (Fig. 2b) . The concept of an RNA binding domain also being used as a protein-protein interaction domain has been observed for other splicing regulators, such as U1A 20 and U2AF65 (refs. 21,22) .
The ZnF4-ZnF4 interface in the crystal, which buries 1,320 Å 2 of protein surface, is defined by hydrophobic and hydrogen-bonding contacts involving residues within ZnF4 motifs of both molecules, as well as residues from the N terminus (Arg178 and Arg181) of molecule B and from the C terminus (Ala241, His242 and Gln244) of molecule A (Fig. 2c) . The protein-protein interface blocks the RNA binding surface of the ZnF4 domain of molecule B, but leaves the same surface of molecule A available for RNA binding (Fig. 2d) .
Base-specific adjoining binding pockets in complex There are three sets of protein-RNA interactions observed in the crystal structure of the ZnF3/4 complex with C1-G2-C3-U4-G5-U6 single-stranded RNA (Fig. 2b) . First, ZnF3 of molecule A contacts G5 and C1 nucleotides originating from two separate RNA strands, E and F s . Second, ZnF4 of molecule A contacts the G2-C3-U4 segment of molecule E s . Third, ZnF3 of molecule B binds the G2-C3 dinucleotide step of molecule F. In all three ZnF-RNA recognition events, the guanine and cytosine bases in a 5¢-GC-3¢ context insert into adjoining base-specific binding pockets, resulting in the RNA backbone pointing outward from the protein surface. The RNA strands bound to ZnF3 of molecule A are aligned antiparallel to the RNA bound to ZnF4 of the same molecule, as shown in ribbon (Fig. 3a) and surface ( Fig. 3b) views of the protein in the complex. The RNA binding pockets for G2 and C3 within ZnF3 and ZnF4 adopt the same peptide backbone topology and include one aromatic and one or two conserved arginine side chains. These are highlighted in a ribbon view of the intermolecular contacts involving the G2-C3-U4 segment (Fig. 3c) and the corresponding surface view of G2 and C3 inserted into adjoining binding pockets (Fig. 3d) for ZnF4 of molecule A.
Stacking and hydrogen-bonding contributions to recognition A characteristic feature of the guanine binding pocket in the MBNL1 complex is a conserved subset of aromatic amino acids in the middle of the protein-Phe202 in ZnF3 (Fig. 4) and Tyr236 in ZnF4 (Fig. 4b) -which are inserted between the guanine and cytosine bases. The aromatic ring of Phe202 forms stacking interactions with C1 ( Fig. 4d) and C3 (Fig. 4f) in ZnF3 complexes.
The guanine base in the GC step stacks over the guanidinium group of invariant Arg195 in ZnF3 (Fig. 4a,c) and Arg231 in ZnF4 (Fig. 4b ) complexes, with these arginines being part of the loop segment between the second and the third cysteines of the ZnF3 and ZnF4 domains. The guanine N 2 and N 1 atoms are hydrogen-bonded to sulfur atoms of the first and the third cysteines coordinated to the zinc atom, whereas the guanine O 6 forms a hydrogen bond with the backbone amide group of the residue following the third cysteine of the ZnF domains (Fig. 4a-c) .
The cytosine base in the GC step forms three intermolecular hydrogen bonds through its Watson-Crick edge with the backbone amide and carbonyl groups in each of the three recognition events (Fig. 4d-f ) and an additional fourth hydrogen bond involving the Glu183 side chain oxygen of ZnF3 (Fig. 4d,f) . Conserved Arg186, whose guanidinium group is packed on top of the cytosine ring (Fig. 4d,f) , is the third side chain within the ZnF3 GC binding pocket involved in a stacking interaction with a base. The position of Arg186 is occupied by U4 of G2-C3-U4 bound to ZnF4 (Fig. 4e) , which is anchored in place through a single base-specific hydrogen bond between its N 3 atom and the side chain of conserved Asp180.
The complex also shows a network of intermolecular hydrogenbonding interactions between the RNA sugar-phosphate backbone and the side chains of the ZnF domains (Fig. 4) .
ZnF3/4 preferentially targets two separated GCU steps
In view of our structural results suggesting a chain-reversal loop trajectory for the target pre-mRNA bound to ZnF3/4, we next turned to RNA sequences containing two GCU trinucleotides separated by an intervening sequence as a potential ligand of the MBNL1 ZnF3/4 domain. Previous studies have identified two MBNL1 binding motifs in both human and chicken cTNT intron regions adjacent to alternative exons 3 . In human cTNT (hcTNT) pre-mRNA the two GCU triplets, which constitute two binding sites, are separated by 10 nt ( Supplementary Fig. 4a online) , whereas in chicken cTNT pre-mRNA they are separated by 25 nt 3 . We performed binding studies of ZnF3/4 with a hcTNT 5¢-UCGCUUUUCCCCUCCGCU-3¢ 18-nt pre-mRNA fragment, which spans residues 23-40 upstream of exon 5 (Supplementary Fig. 4a ). ZnF3/4 binds this 18-nt RNA with 1:1 stoichiometry as determined by an electrophoretic mobility shift (gel-shift) assay (EMSA; Fig. 5a ).
For a quantitative estimation of binding efficiency between MBNL1 ZnF3/4 and the 18-nt hcTNT RNA, protein fluorescence intensity was measured as a function of RNA concentration (Fig. 5b) . Addition of 18-nt hcTNT RNA results in 90% quenching of the intrinsic tyrosine fluorescence of ZnF3/4. The shorter RNA sequences CGCUGU, used for crystallographic studies, and UGCU also affect protein fluorescence, causing approximately 90% and 70% quenching, respectively, at the highest concentrations used (3 mM). The fluorescence titration data yielded a K d of 40 ± 10 nM for ZnF3/4 binding to 18-nt hcTNT RNA, indicative of strong interactions between ZnF3/4 and the RNA ligand containing two GCU binding sites separated by a 10-nt sequence.
Effect of spacing between the two GCU sites
We have compared ZnF3/4 binding affinities for the unmodified hcTNT 18-nt fragment containing a 10-nt spacer between GCU sites (S10), against modified sequences with decreased (S5) and increased (S15) spacer elements, as part of an effort toward validation of the proposed model involving a chain-reversal loop RNA trajectory induced by MBNL1 complex formation. Similar to S10, ZnF3/4 binds S15 with 1:1 stoichiometry as determined by gel-shift assays (Fig. 5c) . No clear band shift was observed for S5 upon adding the equivalent concentration of ZNF3/4. However, smearing of the S5 band at a 3:1 protein:RNA ratio may be indicative of a weak protein-RNA interaction (Fig. 5c) . The similar binding affinities measured for S10 (K d ¼ 40 ± 10 nM) and S15 (K d ¼ 50 ± 20 nM), together with the approximately 3.5-fold lower binding affinity measured for S5 (K d ¼ 140 ± 30 nM) (Fig. 5d) , as measured from fluorescence-monitored titration studies, are consistent with an optimal spacer length of between 10 and 15 nt.
DISCUSSION
We outline below the key features associated with GC-specific recognition by the ZnF domains of MBNL1 and how chain-reversal of the RNA trajectory upon binding the bipartite ZnF3/4 architecture of this splicing regulator could facilitate regulation of alternative splicing of pre-mRNAs. We anticipate that such MBNL1-mediated sequestration of splice-site junctions could prevent access to the splicing machinery, thereby facilitating exon skipping and the formation of alternatively spliced constructs.
MBNL1 ZnF3/4 domains primarily target GC steps
Molecular recognition between MBNL1 ZnF3 and ZnF4 with the GCcontaining steps of its RNA target is dominated by intermolecular stacking and hydrogen-bonding interactions, such that ZnF3 specifically targets the GC dinucleotide step (Fig. 4a,c,d,f) and ZnF4 targets the GCU trinucleotide step (Fig. 4b,e) . The guanine and cytosine bases of the GC step are inserted into adjoining binding pockets of ZnF3/4 ( Supplementary Fig. 5 online) , which are composed of conserved aromatic, arginine and lysine side chains. The Watson-Crick base edges of guanine (Fig. 4a-c) and cytosine ( Fig. 4d-f) within the GC step form intermolecular hydrogen bonds primarily with backbone amide and carbonyl groups as well as the two zinc-coordinated cysteines that line the bottom of the adjoining binding pockets. (1) in Methods. (c) EMSA data for binding of S10, S5, S15 and GC/AU to wild-type (WT) ZnF3/4 and for binding of S10 and GC/AU to the E187P D223T mutant, in which Glu187 and Asp223 have been replaced by the residues that occupy equivalent positions in TIS11d. The original hcTNT 18-nt RNA fragment (S10) and modified sequences (S5 and S15) contain 10-nt, 5-nt and 15-nt spacers, respectively, between the two GCU cites. The spacer regions in the sequences are underlined. GC/AU is the reverse of S10, with 5¢-GC-3¢ to 3¢-AU-5¢ replacements. (d) Plots of relative fluorescence intensity for MBNL1 ZnF3/4 as a function of oligonucleotide concentration. Black, blue and red dots represent mean ± s.d. for at least two independent measurements for S10, S5 and S15, respectively. Solid lines indicate nonlinear least-squares fit according to equation (1) Somewhat similar interactions have been reported for extruded guanines that insert into binding pockets in RNA complexes of CCHC zinc knuckle domains of retroviral 23 and HIV-1 (ref. 24 ) nucleocapsid proteins, as well as in the complex of the fourth C 2 H 2 zinc finger of TFIIIA with loop E of 5S rRNA 25, 26 .
The GC sequence specificity of MBNL1 seems to have biological relevance because simultaneous mutation of four guanines within the two MBNL1 binding sites of a hcTNT minigene substantially (100-fold) reduces the ability of MBNL1 to cross-link with this RNA, as well as its ability to regulate splicing of hcTNT exon 5 (ref.
3). Similar observations have also been reported in independent binding studies using a hcTNT 50-nt RNA construct (residues 8-58 upstream of exon 5) and MBNL1 (residues 1-260) 27 .
Significance of antiparallel aligned tandem ZnF domains
The antiparallel orientation of the RNA strands bound by ZnF3 and ZnF4 in the crystal structure of the MBNL1 ZnF3/4-r(CGCUGU) complex has not been reported previously for other tandem CCCH ZnF domain proteins 19 and is indicative of a chain-reversal loop trajectory for the bound MBNL1 RNA target, given the separation between the two ZnF binding sites. A working model involving the binding of all four ZnF domains of MBNL1 to a long RNA is shown in Supplementary Figure 4b .
A similar antiparallel alignment topology has been reported previously for the tandem RNA binding RRM3 and RRM4 domains of the polypyrimidine tract-specific splicing regulator PTB 28 . The RRM3 and RRM4 domains of PTB form a heterodimer mediated by an extensive hydrophobic interface, whereas their RNA binding surfaces point away from each other, with the bound 6-nt RNAs aligned in an antiparallel orientation. For such an alignment of RNA binding sites, the PTB RRM3/4 heterodimer has the capacity to bring two remote RNA pyrimidine tracts within B30 Å of each other 28 . This distance is comparable to the B20 Å separating the two GC RNA binding sites in the MBNL1 ZnF3/4 complex. Thus, MBNL1 and PTB, both alternative-splicing regulators, share similar antiparallel arrangements of their RNA binding sites on opposing faces of the heterodimer, thereby achieving optimal binding of their RNA targets found in multiple copies within intronic regions near the alternatively spliced exons and in the regulated exons themselves.
Model of MBNL1-mediated pre-mRNA splicing repression A possible model for the repression of exon 5 in the hcTNT premRNA by MBNL1 could involve direct MBNL1 binding upstream of the regulated exon, thereby inhibiting recognition of the 3¢ splice site by the splicing machinery ( Supplementary Fig. 4c ), culminating in exon skipping 27 . The crystal structure of ZnF3/4 bound to two antiparallel RNAs supports the induction of a stable RNA chainreversal conformation as a result of MBNL1 binding to two distant GC/GCU motifs. In support of this hypothesis, mutations that induce stem-loop formation by residues 18-43 upstream of hcTNT exon 5 strongly repressed exon 5 inclusion, independently of MBNL1 (ref. 27 ). The 18-nt hcTNT sequence (residues 23-40 upstream of exon 5) contains high-affinity MBNL1-substrate GCU steps separated by a putative pyrimidine tract ( Supplementary Fig. 4a) , which, following binding by MBNL1, could become less accessible for recognition, thus additionally contributing to splicing repression.
Comparison of RNA-bound MBNL1 and TIS11d complexes
The crystal structure of the MBNL1 ZnF3/4-r(CGCUGU) complex reported in this study can be compared with the previously reported NMR-based solution structure of the TIS11d protein composed of tandem CCCH ZnF domains bound to an AU-rich RNA element 19 . There are notable similarities in the structure-based sequence alignment of the first and second ZnF domains within the tandem ZnF repeats of MBNL1 ZnF3/4, MBNL1 ZnF1/2 and TIS11d ZnF1/2, as outlined in Figure 6a . Superpositioning of MBNL1 ZnF3 (Glu183 to His204) and TIS11d ZnF1 (Glu157 to His178) domains in the RNAbound state (Fig. 6a-c) results in a pairwise Ca r.m.s. deviation of 1.2 Å , establishing that individual ZnF domains adopt similar folds in MBNL1 and TIS11d proteins.
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The main difference between the structures of the two complexes originates with the linker regions connecting the tandem ZnF domains in each of the proteins. Whereas the linker between MBNL1 ZnF3 and ZnF4, both in the free and RNA-bound state, is highly structured through its participation in b-sheet formation (Fig. 6a,b) , the corresponding linker connecting TIS11d ZnF1 and ZnF2 adopts an extended conformation in the complex, except for a 3 10 -helix at the beginning of the linker (Fig. 6a,c) . As a result, the relative orientations of the tandem ZnFs are dramatically different between the MBNL1 (Fig. 6b) and TIS11d (Fig. 6c) complexes. MBNL1 ZnF3/4, in which the tandem ZnF domains are aligned in an antiparallel orientation such that their RNA binding surfaces face away from each other, cannot bind two GCU recognition motifs unless they are separated by a linker sequence (Fig. 6b) . By contrast, the RNA binding surfaces of the tandem ZnF1/2 domains of TIS11d are in register on the same face of the protein (Fig. 6c) , thereby facilitating binding to adjacent UAUU sequences within the 9-nt RNA target.
To compare sequence-specific protein-RNA interactions, we superimposed ZnF3 (molecule B) of the MBNL1 ZnF3/4 complex and ZnF1 of the TIS11d ZnF1/2 complex. The G2 and C3 bases bound by MBNL1 ZnF3 (Fig. 6d) seem to occupy positions equivalent to the U8 and A7 bases, respectively, bound by TIS11d ZnF1 (Fig. 6e) . The conserved aromatic side chains Tyr170 and Phe176 are involved in stacking interactions with U8 and A7, respectively, in the TIS11d complex (Fig. 6e) . The equivalent two conserved residues in the MBNL1 complex are Arg195 and Phe202, and these residues stack in an equivalent manner with G2 and C3, respectively (Fig. 6d) . The flanking RNA bases U6 and U9 of the U6-A7-U8-U9 tetranucleotide bound by TIS11d ZnF1 contribute to binding through formation of U6-Phe176-A7 and U8-Tyr170-U9 stacks.
Notably, sequence specificity of MBNL1 for the 5¢-GC-3¢ step (Fig. 6d) and that of TIS11d for the 3¢-UA-5¢ step (Fig. 6e) is achieved by a similar network of intermolecular hydrogen bonds with the RNA bases. Suffice to highlight that G2 in the MBNL1 complex (Fig. 6d) occupies a similar position to U8 in the TIS11d complex (Fig. 6e) , and both use overlapping sets of backbone and side chains for RNA recognition. Similarly, an overlapping set of RNA-recognition elements target C3 in the MBNL1 complex (Fig. 6d) and the identically positioned A8 in the TIS11d complex (Fig. 6e) . Notably, the RNA chains run in opposite directions relative to the ZnF scaffold in the MBNL1 (Fig. 6d) and TIS11d (Fig. 6e) complexes, implying that sequence specificity of RNA recognition by tandem CCCH ZnF domains seems to depend on the directionality of the bound RNA.
5¢-GC-3¢ versus 3¢-UA-5¢ recognition specificity Structural similarities of the MBNL1-GC (Fig. 6d) and TIS11d-AU (Fig. 6e) binding pockets suggest that MBNL1 could perhaps bind a substrate containing a 3¢-UA-5¢ instead of a 5¢-GC-3¢ dinucleotide. To test this hypothesis, we have used EMSAs to monitor the binding of ZnF3/4 to the reverse sequence of a hcTNT 18-nt RNA substrate in which the two 5¢-GC-3¢ steps are replaced by 3¢-UA-5¢ steps (referred as GC/AU in Figure 5c ). We detected no binding of this AU-containing RNA substrate to MBNL1 by EMSA.
We have tested the contribution to RNA binding of conserved acidic MBNL1 residues Glu187 in ZnF3 (Fig. 4d) and Asp223 in ZnF4 (Fig. 4e) , which are involved in intermolecular recognition of the 2¢-OH group of cytosine. The E187P D223T double mutant, in which the two conserved acidic residues of MBNL1 are replaced by their TIS11d counterparts (Fig. 6a) , showed undetectable binding for both unmodified S10 and GC/AU 18-nt substrates (Fig. 5c) . Thus, disruption of backbone interactions in the E187P D223T mutant of MBNL1 resulted in a substantial loss in binding affinity for the unmodified S10 substrate, but did not enhance the binding affinity for the GC/AU sequence.
Dual role of MBNL as a splicing repressor or enhancer Our efforts in this paper have focused on a mechanistic understanding of MBNL1's role as a splicing repressor. Nevertheless, MBNL1, like some other splicing regulators, can act as either a splicing repressor or as an enhancer, depending on gene context. The location of MBNL1 binding sites relative to the regulated exon may be an important determinant of the probable alternative-splicing outcome, as has been shown for the brain-specific splicing regulator NOVA 29 . One possibility accounting for its enhancer capabilities is that MBNL could target GC steps in the pre-mRNA to bring the 5¢ splice site and the branch point into close proximity to stimulate splicing, as has been proposed for hnRNP A/B and hnRNP H/F splicing factors 30 .
METHODS
Protein and RNA preparation. We cloned the PCR-amplified cDNA fragments encoding human MBNL1 ZnF1/2 (9-90) and ZnF3/4 (178-246) into a modified pET28b vector that adds a Ulp1 protease-cleavable His 6 -Smt3-tag at the N terminus. The recombinant proteins were expressed in Escherichia coli strain BL21-CodonPlus(DE3)-RIL (Stratagene) in LB medium containing 0.1 mM ZnCl 2 . The proteins were purified from the soluble fraction by a nickel-chelating affinity column, followed by His 6 -Smt3 tag cleavage with Ulp1 protease and additional purification by sequential chromatography on monoQ (to bind His 6 -Smt3) and Superdex 75 columns (Amersham). 15 N-labeled MBNL1 ZnF1/2 and ZnF3/4 for NMR studies were expressed as described 31 . Unlabeled and 15 N-labeled proteins were purified in a similar fashion.
RNA oligonucleotides were commercially synthesized (Dharmacon Research), deprotected and purified by anion-exchange chromatography, followed by desalting.
Crystallization and data collection. We crystallized each of two tandem zincfinger domains of human MBNL1 protein (isoform 2, 370 amino acids; Gen Bank NM_207292) using ZnF1/2 and ZnF3/4 constructs (Fig. 1b) . Crystals of MBNL1 ZnF1/2 and ZnF3/4, as well as the complex of ZnF3/4 with bound 6-nt RNA, were grown by hanging drop vapor diffusion. Crystallization conditions were determined with sparse-matrix screens (Hampton Research). ZnF1/2 was crystallized by mixing 1 ml of 1.0 mM protein solution in 0.2 M NaCl, 25 mM Tris-HCl, pH 7.2, and 1 mM DTT with 1 ml of reservoir solution containing 20% (w/v) PEG4000, 20% (v/v) isopropanol and 0.1 M sodium citrate. Free ZnF3/4 was crystallized by mixing 1 ml of 1.2 mM protein solution in the same protein buffer with 1 ml of reservoir solution containing 18% (w/v) PEG3350, 0.01 M magnesium acetate, 0.2 M NaF, and 0.1 M HEPES, pH 6.8. Droplets were equilibrated against 1.0 ml reservoirs at 4 1C. To obtain MBNL1 ZnF3/4-r(CGCUGU) crystals, equal volumes of protein-RNA complex (1:2 ratio; protein concentration was 0.4 mM in 0.1 M NaCl, 25 mM Tris-HCl, pH 7.2, and 1 mM DTT) and reservoir solution (25% (w/v) PEG3350, and 0.1 M Bis-Tris, pH 5.5) were mixed and equilibrated at 4 1C.
For data collection, crystals were flash frozen (100 K) in the above reservoir solutions supplemented with 20% (v/v) ethylene glycol. SAD data sets were collected on the MBNL1 ZnF1/2 crystals (2.7-Å resolution) and on the MBNL1 ZnF3/4 crystals (1.5-Å resolution) at wavelength 1.2827 Å , corresponding to the zinc absorbance edge. A native (1.7-Å resolution) data set was collected on crystals of the MBNL1 ZnF3/4-r(CGCUGU) complex at wavelength 0.9795 Å . All diffraction data were collected on the 24-ID beamline at the Advanced Photon Source (APS). The data were processed by HKL2000 (ref. 32) . The crystals of MBNL1 ZnF1/2 belonged to space group P3 1 , with one protein molecule per asymmetric unit. The crystals of free and RNA-bound MBNL1 ZnF3/4 belonged to space group P2 1 , with four protein molecules or protein-RNA complexes per asymmetric unit. Crystal and diffraction data characteristics are summarized in Table 1 .
Structure determination and refinement. The program SHELEXD 33 was used to locate two and eight zinc sites in the crystallographic asymmetric units of the free ZnF1/2 and ZnF3/4 crystals, respectively. The program SHARP 34 was used to calculate SAD phases. The phases were further improved by density modification and solvent flipping, using the SOLOMON program 35 . The electron-density map was calculated in the CCP4 suite 36 . Automatic ZnF3/4 protein model building was performed with WARP 37 . The resulting protein models were completed manually using TURBO-FRODO 38 . The structure of the MBNL1 ZnF3/4-r(CGCUGU) complex was determined by molecular replacement with MOLREP in the CCP4 suite 36 , using the free protein structure as the search model. The RNA model was built manually using one strand of an idealized 6-nt RNA duplex. The final models were refined using REFMAC 39 . All protein residues are in allowed regions of the Ramachandran plot as evaluated using PROCHECK from CCP4. Refinement statistics are given in Table 1 and a portion of the electron-density map corresponding to the GCU segment of the complex shown in Supplementary Fig. 1 .
Gel electrophoretic mobility shift binding assays. Protein-RNA binding interactions were evaluated by EMSA. MBNL1 ZnF3/4 and RNA were mixed in 50 mM Tris-acetate, 10 mM potassium acetate, 50 mM NaCl, 0.1 mM zinc acetate, 10% (v/v) glycerol and 1 mM DTT, pH 8.0, for a final sample volume of 10 ml. The concentration of RNA was 50 mM, whereas that of the MBNL1 ZnF3/4 construct ranged from 0 mM to 250 mM. After a 20-min incubation at 20 1C, samples were separated by 9% nondenaturing PAGE carried out at a constant voltage of 6 V cm -1 at 4 1C in 50 mM Tris-acetate, pH 8.0, containing 10 mM potassium acetate and 0.1 mM zinc acetate. RNA and protein were visualized with Toluidine and Coomassie, respectively.
Fluorescence measurements. The MBNL1 ZnF3/4 protein contains conserved tyrosines at positions 188, 224 and 236 (Fig. 1c) , rendering it suitable for fluorescence studies 40 . Tyr188 and Tyr224 stack against the side chains of zinccoordinated His204 and His238, and Tyr236 intercalates between the guanine and the cytosine bases in the complex. Steady-state intrinsic tyrosine-fluorescence emission spectra of the MBNL1 ZnF3/4 protein were recorded over the wavelength range 295-400 nm, with an excitation wavelength of 280 nm on a Fluoromax-2 spectrofluorometer. Titrations of the protein at a concentration of 0.3 mM in buffer containing 50 mM NaCl, 25 mM Tris-HCl, pH 7.2, and 1 mM DTT with RNA oligonucleotides were performed while monitoring the change of the tyrosine fluorescence of MBNL1 ZnF3/4 at 310 nm. The temperature of the cell compartment was kept at 20 ± 0.1 1C. All spectra were corrected for blank solutions. The spectral bandpass was 5 nm. No inner filter corrections were needed because the contribution to the absorbance at 280 nm by the oligonucleotides was below 0.1 at the highest concentration used.
The apparent dissociation constant K d and the fluorescence intensity f at saturating concentrations of RNA were determined graphically by plotting the relative fluorescence intensity I/I o versus the concentration of RNA 41 . The theoretical curves were fitted to the experimental data points by nonlinear leastsquares analysis using the equation
where I o is the fluorescence intensity of the RNA-free protein and N o and P o are total RNA and protein concentrations, respectively. Fluorescence measurements were repeated to verify the dissociation constants. 
